Brainstorm Cell Therapeutics reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Adamis Pharmaceuticals ADMP:US 0 0
Biogen BIIB:US $ 6275.7M 1.7M
Brainstorm Cell Therapeutics BCLI:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Cytokinetics CYTK:US $ 197.08M 54.24M
Gilead Sciences GILD:US $ 25183M 4M
Halozyme Therapeutics HALO:US $ 788.1M 0.84M
Idera Pharmaceuticals IDRA:US $ 0M 0M